(reported by the Company)
No items found
Vaxxas is focussed on enhancing the performance of existing and next generation vaccines through the development and commercialization of the company's novel vaccine delivery technology - the Nanopatch™.
|Category:||Health & biotech|
|ASX Listing Code (if applicable):|
|Year of Commencement:||2011|
c/o - OneVentures Management
|State:||New South Wales, Queensland|